Dorsey & Whitney Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $266K | Buy |
506
+145
| +40% | +$76.1K | 0.01% | 568 |
|
|
2025
Q1 | $229K | Sell |
361
-275
| -43% | -$174K | 0.01% | 601 |
|
|
2024
Q4 | $453K | Sell |
636
-84
| -12% | -$59.8K | 0.03% | 418 |
|
|
2024
Q3 | $757K | Buy |
720
+271
| +60% | +$285K | 0.04% | 314 |
|
|
2024
Q2 | $472K | Sell |
449
-138
| -24% | -$145K | 0.03% | 368 |
|
|
2024
Q1 | $565K | Buy |
587
+124
| +27% | +$119K | 0.04% | 335 |
|
|
2023
Q4 | $407K | Sell |
463
-41
| -8% | -$36K | 0.03% | 382 |
|
|
2023
Q3 | $415K | Buy |
504
+7
| +1% | +$5.76K | 0.04% | 350 |
|
|
2023
Q2 | $357K | Buy |
497
+206
| +71% | +$148K | 0.03% | 395 |
|
|
2023
Q1 | $239K | Buy |
291
+8
| +3% | +$6.57K | 0.02% | 485 |
|
|
2022
Q4 | $204K | Buy |
+283
| New | +$204K | 0.02% | 528 |
|